World Wide Trends - Pagina 16 di 17

16 maggio 2023

North America Is Dominating Microfluidic Devices Industry

The total value of the global microfluidic devices market was USD 14,218.6 million in 2021, and it will rise at a growth rate of above 17.3% shortly, reaching USD 59,785.3 million by 2030, according to P&S Intelligence.

Microfluidics is a developing scientific area with an extensive variety of logical applications and commercial diagnoses in the arenas of cell biology research, protein crystallization, and medicine. Therefore, this technology is a vital tool to decrease side effects and advance the effectiveness of treatments.

Furthermore, the requirement for micromachined biological tools is projected to grow considerably in the coming few years, driven by the development of genomics and proteomics studies, and also the aimed incorporation of lab-on-a-chip tools into laboratory measures.

In Asia-Pacific, China is one of the fastest-rising industries for microfluidics because of the growing government backing and refining of healthcare amenities. Consequently, APAC is projected to arise as an appealing industry for businesses manufacturing like medicinal instruments.

Whereas, in Europe, the industry is boosted by the growing diagnosis needs, credited to the refining healthcare amenities and the increasing occurrence of illnesses; itself because of the lifestyle changes and elderly populace.

In 2021, the polymer category led the industry with a share of approximately 60%. the polymer has experienced a substantial surge in the application, specifically in the rapid prototyping of microfluidic devices, credited to the material’s comfort of fabrication into items and reduced price. Moreover, new surface alterations are being launched to resolve the difficulties brought on by the hydrophobicity of polymers.

Hence, the industry for microfluidic devices is boosted by their increasing utilization in genomic and proteomic research.

15 maggio 2023

North America Is Dominating Sleeping Aids Industry

The sleeping aids market is projected to be USD 157,484.5 million by 2030 growing at a CAGR of 7.3% during the forecast period, according to the estimates of the market research company, P&S Intelligence.

In 2021, North America held the largest revenue share approximately 50% in the market. This dominance can be credited to the rising frequency of sleep disorders and several initiatives by non-government and government organizations to spread awareness about the associated disorders and sleep hygiene.

In 2021, the size of the APAC sleeping aids market was $15 billion, and it is projected to grow at the highest rate in the years to come. Several sleeping disorders, like sleep apnea, sleepwalking, narcolepsy, insomnia, and restless leg syndrome need intervention, to avoid serious damage.

Majorly, the revenue in the industry is growing in APAC because of the high consumption of sleeping pills due to the changing lifestyle, long working hours, stress, and rising awareness about sleep disorders. Such reasons are growing the sales of sleeping aids.

The increasing acceptance of wearable monitoring devices and sensors is driving the market. Such devices support in transmission and record data related to several physiological conditions, for measuring and monitoring sleep quality. Some of the wearable sensors and monitors presented are BioHarness by BIOPAC Systems Inc., LifeVest by ZOLL Medical Corporation., LifeShirt by Aegis Limited, Zio XT by iRhythm Technologies Inc., and Sense Wear Armband by Jawbone.

Moreover, these devices are easy to use which makes them popular among people suffering from these disorders. Thus, with the increasing help from the usage of these instruments to monitor sleep quality, the requirement for sleeping aids is projected to grow.

In 2021, the Mattresses and pillows category had the highest revenue share, at approximately 40%. The availability of a wide range of international as well as local mattresses and pillows manufacturers makes these products cheaper which leads to their wide acceptance among people.

The Chinese market for products that support the sleep-deprived is rising at a high rate, mainly with youngsters looking to surge the quality and quantity of their sleep. Which indeed is contributing to the growth in the demand for obstructive sleep apnea machines, smart mattresses, and melatonin.

In China, with a growing amount of population suffering from sleep disorders, companies like Xilinmen and Xiaomi are spending more on scientific R&D to provide better products. Furthermore, key players are concentrating on exploring the potential effects of enhanced technology on sleep time.

Hence, the rising occurrence of obstructive sleep apnea, unhealthy routines of individuals, which is noticeable in the fluctuations in sleep and diet and patterns; and huge work pressure, are the major factors driving the sleeping aids market.

12 maggio 2023

North America Is Dominating Clinical Nutrition Industry

The clinical nutrition market size stood at USD 37.8 billion in 2021, which is expected to reach USD 70.8 billion by 2030, advancing at a CAGR of 7.2% during 2021–2030, as per P&S Intelligence.

This growth can be ascribed to the growing elderly population, a lift in the frequency of lifestyle-associated illnesses, a high birth rate and a high number of premature births, surging number of malnutrition sufferers, and athletes’ acceptance of sports nutrition items because of their several benefits.

The constant growth in the economic value of major operating businesses provides them with a competitive edge, for the innovation of new solutions. Additionally, corporations are constantly working to advance their current product line to maintain their dominating position. Therefore, corporations’ new growth strategies and foray into undeveloped regions to widen their reach are projected to drive the market.

The developing countries of LATAM, APAC, and MEA, including Brazil and India, are projected to contribute significantly to the market growth, as the major players are investing heavily in order to establish their footprint in such countries. The requirement for clinical nutrition in such countries is expanding with the rising geriatric and patient populations.

The cancer category is growing at a considerable rate in the clinical nutrition market, because of the growing cancer frequency globally. Products for enteral nutrition are considered an important solution for cancer treatment, as they avert nutritional deficiencies in the body, thus guaranteeing the proper functioning of many organs.

Cancer patients require a healthy diet because the illness might vary rate at which their bodies process nutrients and the degree to which this happens. Patients should get constant nutrient feedings as they are prone to becoming malnourished and losing weight.

North America, was responsible for the majority of clinical nutrition items sales, generating approximately 40% of the worldwide revenue, in 2021. The high frequency of cancer and disorders related to lifestyles involving a 9-to-5 desk job, a huge number of participants, and better reimbursement guidelines in comparison to other regions are some of the major reasons propelling the market growth.

Moreover, the well-developed healthcare infrastructure in the continent, high per capita income, and high healthcare investment are major factors contributing to the rising demand for clinical nutrition.

The APAC market is projected to witness the highest CAGR, of above 9%, in the coming years. This can be credited to the mounting geriatric population, snowballing birth rate, and high malnutrition rates in the region.

Hence, with the rising count of patients, booming geriatric population, and high count of prematurely born babies, the demand for clinical nutrition products continues to increase.

11 maggio 2023

Why do We Need Anti-Aging Treatments and Products in Modern Era?

An intricate biological process, skin aging is influenced by both external and internal factors. Women seem to favor anti-aging products the most. Mostly, women place a lot of position on having beautiful hair and skin.

Therefore, various anti-aging procedures and treatments have been introduced. People are increasingly more conscious about their appearance and health today.

Consumers are increasingly ready to spend money on these items for personal care due to the rising popularity of a variety of at-home gadgets for skin rejuvenation, cellulite reduction, wrinkle reduction, and microdermabrasion. These lightweight, convenient devices are also continually improved.

The use of at-home products is expanding internationally as individuals search for ways to retain their young appearance and the senior population concentrates on strategies to delay the onset of aging. The anti-aging market is predicted to touch $422,804.6 million by 2030.

Moreover, numerous conferences, exhibits, and conferences are being held all over the world to inform the public, plastic surgeons, and students about developments in anti-aging therapies. Therefore, a lot of players are actively participating in these exhibits and events to increase awareness of their goods.

People are becoming increasingly aware of the many issues related to aging skin, including fine lines, dullness, wrinkles, decreasing plumpness, and smoothness, in both emerging and established nations.

Make inquiry before purchase of this report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=anti-aging-market

In addition, the accessibility of cost-effective goods and solutions, increasing middle-aged consumer buying power, increasing personal disposable income, and growing standards of living are some of the other reasons that are significantly influencing the requirement for these products.

Retail establishments, drug shops, and internet retailers all serve as important distribution channels for growing sales. Among them, the internet category has been expanding quickly because of consumers’ growing preferences, ease of shopping, and increased after-sales services.

As a result, businesses and brands are diligently attempting to sell their inventory both online and offline to increase sales income.

Furthermore, hormonal changes brought on by delivery, pregnancy, menopause, and thyroid issues; genetic makeup that changes with age; side effects of numerous drugs & treatments; radiation exposure during treatment or other illnesses; a stressful lifestyle that promotes hair thinning; and excessive reliance on chemical sprays for hairstyling are some of the key reasons of hair loss.

In addition, problems with sleep, digestion, worry, and sadness inhibit hair development. Thus, this increases the demand for hair restoration procedures all over the world.

The elasticity and tightness of skin can be improved with the use of technologically enhanced products and techniques. They aid in the efficient treatment of wrinkles, fine lines, cellulite, and sunspots to improve skin firmness.

The efficacy and non-invasiveness of such items and methods are major advantages. These benefits have significantly enhanced the popularity of such solutions for use in hospitals and clinics as well as at home.

Additionally, the expansion of the business is being aided by the rising number of surgical and non-surgical operations being carried out in the area. For instance, the most common surgical treatments carried out in European nations include liposuction, breast augmentation, rhinoplasty, eyelid surgery, and abdominoplasty, whilst derma filler, Botox, and chemical peel are common non-surgical procedures.

10 maggio 2023

Boom Predicted in North American Dermatology Drugs Industry in Future

The global dermatology drugs market attained a value of $25,228.2 million in 2019 and is predicted to generate a revenue of $55,425.0 million by 2030.

According to the estimates of P&S Intelligence, a market research company based in India, the market would progress at a CAGR of 8.8% between 2020 and 2030. The surging geriatric population, the rising prevalence of skin diseases, and the soaring disposable income of people are the main factors driving the progress of the market.

The growing incidence of skin diseases in various countries is the biggest factor propelling the expansion of the dermatology drugs market across the world. Genetic and environmental factors, trauma, and aging are the main factors responsible for skin ailments. As per the World Health Organization (WHO), nearly 900 million people all over the world suffer from skin diseases at any particular time. Furthermore, skin problems are among the most-prevalent human health diseases across the world.

In the U.S., acne is the most prevalent skin disease and affects as many as 50 million Americans every year. As per the National Eczema Association, in the U.S., 31.6 million people were diagnosed with eczema in 2019. Due to the high prevalence of these diseases, the sales of dermatology drugs are growing rapidly across the globe. Besides this factor, the increasing public awareness of skin diseases is also positively impacting the growth of the dermatology drugs market.

Numerous medical product organizations are initiating programs for raising awareness about skin ailments. For example, Kisaco Research conducted Microbiome Connect Skin USA, which is a virtual summit, in June 2020 for recognizing the value of various skin-microbiome-based items as the next step in a person’s skincare regimen. Depending on prescription mode, the market is classified into over-the-counter (OTC) drugs and prescription drugs. Between these, the prescription drugs category recorded higher growth in the market in the past.

This was because of the availability of several prescription drugs, the high public preference for consultations with dermatologists, particularly for chronic skin ailments, and the high public awareness about skin problems. When end user is taken into consideration, the dermatology drugs market is classified into clinics, hospitals, cosmetic centers, and at-home settings. Out of these, the cosmetic centers category is predicted to register the fastest growth in the market in the future years.

This would be because of the rising focus of people all over the world on their appearance, the increasing number of cosmetic centers, and highly affordable beauty services provided in these facilities. Globally, the dermatology drugs market is predicted to exhibit the highest growth in North America in the upcoming years, on account of the growing public awareness of skin ailments and their skincare regiment and the existence of several established industry players in the regional countries.

Thus, it is quite clear that due to the growing prevalence of skin diseases and the increasing public awareness about the treatment of these diseases, the market would register huge expansion across the globe in the coming years.

9 maggio 2023

Wide Application of Cleanroom Consumables in Pharmaceutical Industry

The cleanroom consumables are utilized for maintaining cleanliness in a controlled environment. It ensures efficient and safe operations.

The cleanroom consumables industry has garnered $9,462.25 million revenue in 2021, and it is projected to generate $14,957.72 million, rising at a rate of 5.22% from 2021 to 2030. The growing demand for electric gadgets fuels the sales of consumables in the healthcare industry.

Moreover, the advancements in the changing consumer lifestyles boost the packaged food products demand with longer shelf life and sterility that provide better convenience.

The increasing R&D activities for developing vaccines against COVID-19 have encouraged pharmaceutical and biopharmaceutical businesses to massively invest in the development of a contamination-free environment.

Furthermore, cleanroom consumables are utilized in various industries, such as pharmaceutical, biotechnology, nanotechnology, and electronics industries. Buyers are aware of the importance of cleanroom consumables. It results in the growing demand for such products.

The massive availability of raw materials such as cellulose, rubber, polymers, and alcohol reduce the bargaining strength.

Gloves: These are automatically engineered so that they can fit on anyone’s fingers and are worn over the hands during working in the cleanroom. Such wearables offer comfort, strength, durability, flexibility, and appreciable electrostatic discharge performance. Surgical gloves are required for performing numerous surgeries and other medical procedures for maintaining hygiene.

Apparel: It is usually made non-shedding and lint-free, and worn in a controlled atmosphere. The manufacturing of such apparel complies with stringent regulations, to avoid the usage of several materials in their manufacturing, to prevent contaminant transmission between the cleanroom and wearer.

Wiper: A wiper is utilized inside the cleanroom for removing surface pollutants from the working area. They come in numerous sizes, materials, and textures that meet the user’s requirements. These are made of materials, such as polypropylene, cellulose, polyester, nylon, and cotton.

Adhesive mats: These are dust and dirt absorption pads that can be utilized at the entrance and walkways. These are made of several polyethylene sheets positioned on top of each other with the application of adhesive between the layers. The uppermost layers are removed after usage to reveal the fresh layer composed of adhesive.

Moreover, cleaning products are utilized in such facilities, as they are made of specialty materials for removing pollutants, including dirt, stains, dust, and chemical spills from the clean rooms. The majorly utilized cleaning products are buckets, mops, squeezes, wringers, validation swabs, and cleaning chemicals.

The major companies operating in the industry are:

1- Valutek Inc.

2- Contec Inc.

3- KM ACT CORP.

4- Texwipe

5- Berkshire Corporation

6- DuPont de Nemours Inc.

7- Kimberly-Clark Corporation

8- Micronova Manufacturing Inc.

9- Valutek Inc.

Therefore, the importance of cleanliness and sanitation to prevent infections, pollutants, and environmental contamination boosts demand for cleanroom consumables.

8 maggio 2023

How Does Nuclear Imaging Support Physicians in Planning Treatment?

The Nuclear imaging procedure is a non-invasive medical test that supports physicians in diagnosing the medical conditions of the patients. Nuclear imaging utilizes the radioisotopes injected, inhaled, or swallowed to generate images that showcase how organs and tissue’s function. The radiation produced by the radioisotope is used for cancer diagnosis, organ disorder evaluation, and investigation the blood circulation. PET imaging helps in identifying active vascular macrocalcification in atherosclerosis cases, by utilizing 18F-sodium fluoride radioactive element.

Under the type segment, the nuclear imaging equipment industry is divided into Hybrid PET, SPECT, and Planar Scintigraphy. SPECT holds a significant share of the nuclear imaging equipment sector. SPECT scan is utilized for the detection of blood flow in veins and arteries. It is highly sensitive to brain injury compared to CT scans and MRI. SPECT scan is performed by injecting a tracer into the body that facilitates producing a picture of the heart for proper blood flow detection.

Under the application segment, the global nuclear imaging equipment industry is divided into cardiology, oncology, neurology, and others. Oncology holds an extensive share of the industry. Under the end-user segment, the industry is divided into research institutes, hospitals, diagnostic centers, and others. Hospitals capture the largest share of the sales of nuclear imaging equipment.

The growing prevalence of cancer, cardiovascular diseases, neurological disorders, and rising elderly population, and surging healthcare expenditure boost the industry growth. Besides this, the product launches by companies to stay on the competitive edge and increase the consumer base also cause industry propulsion.

It is projected that the population aging above 60 years will be around 437 million in China, 107 million in the U.S., and 324 million in India by 2050. The elderly population is more prone to heart diseases; therefore, it is likely to cause a boom in the industry with the growing demand for nuclear imaging equipment.

The rising incidences of cancer and the increasing elderly population contribute to the expansion of the nuclear imaging sector. According to IARC, there will be around 21.4 million cancer patients in 2030. Moreover, the rise in the population undergoing cancer detection tests and cancer screening proliferates the industry.

Nuclear medicine imaging evaluates how organs inside the body function, while other imaging methods only assess the picture of the anatomy. The knowledge of the functioning of an organ provides support to physicians in the diagnosis and planning of the treatments.

The nuclear medicine scans facilitate crucial information that cannot be assessed by other types of testing. It also enhances the quality of the diagnosis and treatment provided to patients. It helps in the discovery of illnesses at the earliest stages.

The major companies operating in the nuclear imaging industry are Siemens AG, Philips Healthcare, Cannon Inc., CMR Naviscan Corporation, Mediso Medical Imaging Systems Ltd., SurgicEye GmbH, DDD Diagnostics, and Neusoft Medical Systems Co.

Therefore, the prevalence of cancer and the rising elderly population leads to the surging demand for the nuclear imaging equipment.

5 maggio 2023

Wearable Injectors Industry Growth and Demand Forecast Report 2030

The wearable injector market will reach a value of USD 20.21 billion, propelling at a rate of 12.6%, by 2030 as per a report by P&S Intelligence. This is mainly due to the growing concerns regarding health hazards because of conventional injectors, along with the increasing demand for conventional and novel drug molecules.

Additionally, the rising cases of chronic diseases, for instance, cancer, diabetes, and cardiovascular diseases, along with beneficial policies will help the industry to grow during the forecast period.

The on-body wearable injector category accounted for the largest wearable injector market share, of over 50%, in recent years, owing to the water resistance and user-friendliness of such patches.

On the other hand, the off-body belt injectors category is expected to witness the highest CAGR, of approximately 13%, in the future, driven by the increasing investments to produce advanced off-body injectors.

APAC will witness the highest CAGR, over 13.2%, by 2030. This is credited to the rising awareness for better healthcare facilities and improving healthcare infrastructure. Additionally, the increasing healthcare expenditure and the government initiatives to support the use of wearable injectors will boost the growth of the market in this region.

Due to the increasing demand for conventional and novel drug molecules, rising concerns regarding conventional injectors, and the increasing incidence of chronic diseases, the wearable injector industry will continue to grow in the coming years.

3 maggio 2023

How Needle-Free Injections Can Boost Success of COVID-19 Vaccination Drives?

Not just children but adults also have needle phobia; therefore, they avoid or try to avoid going to the doctor as much as possible. Thus, many deliberately miss appointments with doctors or may avoid the prescribed treatment that involves this mode of drug administration.

As per research, around two in every three children are afraid of needles. Moreover, on average, 16% of the adults avoid vaccination drives due to trypanophobia. Further, several studies have shown that around one in ten adults have difficulty taking needled injections due to this phobia.

Therefore, mass immunization programs, such as the ongoing ones in the light of COVID-19, face apprehensions from people afraid of needles. There were even reports of people fainting out of fear of vaccines, such as that of one Maguila Júnior in Sao Paulo! Although the viral video of the incident, recorded by his acquaintance, might make you laugh, imagine the psychological trauma Maguila must have gone through then and long after he came to.

Thus, the concept of needle-free injections has been gaining pace for quite some time, as it aims to ensure people do not miss out on important vaccinations. Such devices deliver drugs by applying forces such as shock waves, gas pressure, electrophoresis, and Lorentz through the skin. Hence, in 2021, the needle-free injection systems market stood at $151.0 million; it is expected to advance at a rate of 13.3% from 2021 to 2030, to hit $466.2 million in revenue by 2030.

The needle-free injection technology is backed by international health organizations, such as the Centers for Disease Control and Prevention, World Health Organization, and Bill and Melinda Gates Foundation. Since, these systems are painless, they provide numerous benefits to the pharma industry, the biggest being enhanced patient compliance. It has shown promising results in vaccination programs.

Further, researchers in the Netherlands are developing a laser-technology-based bubble gun to make needle-free, virtually painless injections. With this, scientists aim to make mass vaccination drives more successful, by easing people’s fear with the assurance of zero discomfort. The laser pushes the tiny droplets inside a bubble gun through the outer layer of the skin. The process is faster than a mosquito bite and does not cause any pain, as there is no contact of the device/laser with the nerve endings.

The technology used in the bubble gun facilitates the heating of liquid within milliseconds, and a bubble is formed in the liquid, pushing it at a speed of 60 mph. This injection penetrates the skin without any damage, thus not causing any wound. Researchers believe that this device will quicken up the vaccination process and prevent contamination by dirty or reusable needles, while also minimizing the generation of medical waste.

Therefore, the demand for needle-free injection systems is rising for painless drug administration. This could ultimately increase the participation of people with trypanophobia in mass immunization drives, which is imperative to control common infections, such as COVID, flu, hepatitis A and B, rubella, tetanus, typhus, diphtheria, measles, and even polio.

2 maggio 2023

How Are National and International Organizations Accelerating Aortic Valve Use?

Every year, almost 18 million die of heart diseases, as per the World Health Organization (WHO). Moreover, John Muir Health says that valvular diseases, such as aortic stenosis, are diagnosed in 5 million people each year. Another valvular disease now becoming common is aortic regurgitation, in which the aortic valve doesn’t close properly, causing some of the blood pumped by the left ventricle to fall back into it. As per the WHO, almost 2% of the heart patients across the world have rheumatic heart disease (RHD), which is diagnosed in most people with aortic regurgitation.

With the rising prevalence of this and other diseases that affect the flow of the blood from the left ventricle to the aorta, the aortic valve market size is expected to grow from $7,568.3 billion in 2019 to $29,146.9 million by 2030, at a 13.2% between 2020 and 2030, as per P&S Intelligence. The aortic valve is, anyway, the most-important of the four cardiac valves, as it regulates the flow of oxygen-rich blood from the heart to all parts of the body. As a result, any malfunctioning in it can have detrimental effects on the health of people, even death.

An important factor that increases the risk of all such diseases is age. Old people are physically weaker, which is why their organs and tissues can easily malfunction. As per the United Nations (UN), in 2020, there were 727 million people in the age group of 65 and above in the world, and their number will increase to 1.5 billion by 2050. This will lead to a vast pool of people with cardiac diseases, which would create a surge in the volume of surgeries, including aortic valve replacements.

However, even while MISs are cost-effective compared to open surgeries, they are still costly. This is why Europe has been the largest aortic valve market, also supported by the regulatory approvals being received by an increasing number of such products. Additionally, Europe is home to an advanced healthcare sector, in which the major part of the expenditure comes from governments. Bringing these surgeries closer to patients is the favorable reimbursement scenario here, which makes these procedures more-easily accessible than in developing countries.

Hence, with the cases of diseases of the aortic valve increasing, the demand for its replacements will burgeon too.